Pathophysiological role of blood-borne tissue factor: Should the old paradigm be revisited?

Internal and Emergency Medicine

Volumn 6, Issue 1, 2011, Pages 29-34

  Cimmino, Giovanni ^a,b,c   Golino, Paolo ^b,c   Badimon, Juan Jose ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NONE   (Italy)

Author keywords

Acute coronary syndromes; Blood borne tissue factor; Coagulation; Vulnerable blood

Indexed keywords

BIOLOGICAL MARKER; THROMBOPLASTIN;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; HUMANS; THROMBOPLASTIN;

EID: 79551613742     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0423-4     Document Type: Review

References (50)

1. Aikawa M, Libby P (2004) The vulnerable atherosclerotic plaque: pathogenesis, therapeutic approach. Cardiovasc Pathol 13: 125-138.
2. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ (1997) Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95(3): 594-599.
3. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Lüderitz B, Fallon JT, Fuster V, Badimon JJ (2004) Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109(16): 2001-2008.
4. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9: 458.
5. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler ThrombVasc Biol 20(5): 1262-1275.
6. Nemerson Y (2002) A simple experiment and a weakening paradigm: the contribution of blood to propensity for thrombus formation. Arterioscler Thromb Vasc Biol 22(9): 1369.
7. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22): 2746-2753.
8. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ (2003) Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107(7): 973-977.
9. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH (2001) Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134(3): 224-238.
10. Giesen PL, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96(5): 2311-2315.
11. Tutar E, Ozcan M, Kilickap M, Gülec S, Aras O, Pamir G, Oral D, Dandelet L, Key NS (2003) Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 108(13): 1581-1584.
12. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S (1997) Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 134(2 pt 1): 253-259.
13. Østerud B, Bjørklid E (2006) Sources of tissue factor. Semin Thromb Hemost 32(1): 11-23.
14. Lechner D, Weltermann A (2008) Circulating tissue factor-exposing microparticles. Thromb Res 122(Suppl 1): S47-S54.
15. Rivers RP, Hathaway WE, Weston WL (1975) The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3): 311-316.
16. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, de Gaetano G, Cerletti C (2006) Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 4(6): 1323-1330.
17. Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177(7): 4794-4802.
18. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B (2007) Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109(3): 995-1002.
19. Sovershaev MA, Lind KF, Devold H, Jørgensen TØ, Hansen JB, Østerud B, Egorina EM (2008) No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils. J Thromb Haemost 6(10): 1742-1749.
20. Egorina EM, Sovershaev MA, Olsen JO, Østerud B (2008) Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 111(3): 1208-1216 (Epub 2007).
21. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlägel U, Zahler S, Engelmann B (2001) Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 281: 603-609.
22. Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA (2004) Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 30: 493-500.
23. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203: 2433-2440.
24. Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166: 189-197.
25. Davizon P, López JA (2009) Microparticles and thrombotic disease. Curr Opin Hematol 16(5): 334-341.
26. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A (2009) Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 101(3): 439-451.
27. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, Fisher EA, Schnapp LM, Nemerson Y, Taubman MB (2000) Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87(2): 126-132.
28. Baroni M, Pizzirani C, Pinotti M, Ferrari D, Adinolfi E, Calzavarini S, Caruso P, Bernardi F, Di Virgilio F (2007) Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J 21(8): 1926-1933.
29. Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U (2009) Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 7(5): 871-878.
30. Hathcock J (2004) Vascular biology-the role of tissue factor. Semin Hematol 41(1 Suppl 1): 30-34.
31. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U (2005) Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 96: 1233-1239.
32. Bach RR (2006) Tissue factor encryption. Arterioscler Thromb Vasc Biol 26: 456-461.
33. Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99(3): 348-353.
34. Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. JACC 49: 772-777.
35. Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A (2001) Cell derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85: 639-646.
36. Biró E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R (2003) Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1: 2561-2568.
37. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B (2004) Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104: 3190-3197.
38. Hrachovinová I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH Jr, Schaub RG, McEver RP, Wagner DD (2003) Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 9: 1020-1025.
39. Censarek P, Bobbe A, Grandoch M, Schrör K, Weber AA (2007) Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost 97: 11-14.
40. Hobbs JE, Zakarija A, Cundiff DL, Doll JA, Hymen E, Cornwell M, Crawford SE, Liu N, Signaevsky M, Soff GA (2007) Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 120: S13-S21.
41. Butenas S, Orfeo T, Mann KG (2009) Tissue factor in coagulation. Which? Where? When? Arterioscler Thromb Vasc Biol 29(12): 1989-1996.
42. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, Wakefield TW, Mackman N, Fay WP (2005) Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105: 192-198.
43. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG (2005) Tissue factor activity in whole blood. Blood 105: 2764-2770.
44. Balasubramanian V, Grabowski E, Bini A, Nemerson Y (2002) Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 100(8): 2787-2792.
45. Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, Bernardi F (2006) Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26(12): 2800-2806.
46. Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L, Atherogene Investigators (2007) Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 5: 475-482.
47. Mälarstig A, Tenno T, Johnston N, Lagerqvist B, Axelsson T, Syvänen AC, Wallentin L, Siegbahn A (2005) Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 25(12): 2667-2672.
48. Keller TT, Choi D, Nagel C, Te Velthuis H, Gerdes VE, Wareham NJ, Bingham SA, Luben R, Hack CE, Reitsma PH, Levi M, Khaw KT, Boekholdt SM (2006) Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. J Thromb Haemost 4(11): 2391-2396.
49. Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ (2009) Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost 7(5): 894-897.
50. Butenas S, Undas A, Gissel MT, Szuldrzynski K, Zmudka K, Mann KG (2008) Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 99: 142-149.